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Abstract 
Background: To assess the psychometric properties, including internal consistency, construct validity, criterion 
validity, criterion-group validity, and responsiveness, the Reviewed McGill Quality of Life Questionnaire (MQOL-R), 
into Brazilian Portuguese-(BrP). Also, to analyze the relationship of the BrP-MQOL-R with the scores on the Karnofsky 
Performance Scale (KPS) and on the Numerical Pain Scale (NPS 0–10).
Methods: The BrP-MQOL-R was administered to a sample of 146 adults (men = 78). A team of experts translated 
the MQOL-R according to international guidelines. Convergent validity and Confirmatory factor analysis (CFA) was 
performed.
Results: The BrP-MQOL-R Cronbach’s alpha was 0.85. CFA supported the original four-factor structure, with the fol-
lowing revised model fit-indices: PCLOSE = 0.131, Tucker-Lewis Index (TLI) rho 2 = 0.918, incremental fit index (IFI) 
delta 2 = 0.936. The convergence validity is supported by a significant correlation between BrP-MQOL-R total scores 
and their subscales with KPS and with the single item related to the quality of life. And by a converse correlation with 
the pain scores in the NPS (0–10). Receiver operator characteristics (ROC) analysis showed subjects with KPS equal to 
or lower than 30% could be discriminated from those with scores on KPS higher than 30% by an area under the curve 
(AUC) = 0.71, sensitivity = 97%, and specificity = 92%).
Conclusion: The BrP-MQOL-R proves to be a reliable instrument for assessing the quality of life (QOL) in palliative 
care (PC), with primary evidence of validity. BrP-MQOL-R presented adequate discriminate properties to identify dis-
tinct conditions that impact the QOL in PC.
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Background
Palliative care is specialized medical care for people liv-
ing with a severe illness with a life-threatening disease to 
prevent and relieve suffering through early identification, 
with appropriate evaluation and treatment of pain, physi-
cal, psychosocial, and spiritual problems. The palliative 
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care provides relief from the symptoms to reduce the 
stress of the illness coming to the comfort of suffering 
and improvement of the Quality of Life (QOL) for both 
the patient and the family” [1]. The QOL comprises 
physical, emotional, psychological, and social dimen-
sions. The concept must be contextualized since the term 
“quality of life” can have different meanings. The defini-
tion of QOL refers to patients’ well-being with a termi-
nal disease, including the dimensions mentioned above. 
Accordingly, the McGill Quality of Life Questionnaire 
(MQOL) was developed to measure the QOL of people at 
the end of life, to overcome specific limitations with the 
QOL measures existing: (i) They were too long for pallia-
tive care patients. (ii) They did not assess the existence or 
spiritual well-being. (iii) They focused exclusively on neg-
ative aspects of QOL, even if positive and negative fac-
tors influenced the quality of life [2–5]. Thus, the MQOL 
was developed with particular interest to assess physical 
symptoms (Physical Wellbeing; Physical Symptoms) that 
allow a brief symptom measurement as the Edmonton 
Symptom Assessment System (ESAS) [6, 7]. According 
to an earlier study, physical symptoms are essential pre-
dictors on measuring global QOL, and they have been of 
great importance to people with life-threatening illnesses 
[8].
The McGill Quality of Life Questionnaire-Reviewed 
[9], improved the MQOL version, addressing issues 
that arose during the use of MQOL over the years. The 
results provided a well-adjusted measurement structure 
and expected correlations between each subscale of the 
MQOL-R and MQOL single item scale (SIS). MQOL-
R has strong psychometric properties, and it has been 
widely used in palliative care in both clinical and research 
for the life quality at the end of life assessment. It has 
subscales measuring the four relevant domains: physical, 
psychological, existential/spiritual, and social. It evalu-
ates the physical condition’s impact on the quality of life, 
rather than on the intensity of symptoms. In contrast, 
most other quality life assessment tools at the end of 
life do not include the existential/spiritual domain, have 
a primary focus on physical symptoms, or have many 
more items. An additional advantage of the MQOL-R is 
that it takes approximately 5–10 min to complete a self-
administered in paper and pencil or online format [9]. 
Considering that the area of palliative care is in rapid 
development, and that lack of appropriate instruments to 
assess QOL, this motivated us to translate and adapt of 
the MQOL-R to the Brazilian Portuguese (BrP) within its 
linguistic and sociocultural context.
Thus, we conduct the present study to examine the 
psychometric reliability of the translated MQOL-R for 
the Brazilian population [10]. (I) We evaluated the con-
tent validity and face validity by semantic equivalence, 
the comparison of items by experts, and a sub-sample of 
the target population to assess the cross-cultural, adapted 
from the English version of the Brazilian Portuguese 
(BrP)-MQOL-R. (II) We examined the internal consist-
ency, criteria validity, factor structure, and construct 
validity of the MQOL-R translated instrument. (III) We 
assessed the convergence validity by the correlation of 
the MQOL-R with relevant correlates for the quality of 
life, such as the Karnofsky Performance Scale (KPS) and 
pain levels reported on the Numerical Pain Scale (NPS 
0–10). (IV) We evaluated the criterion validity by the 
ability of MQOL-R to discriminate between subjects 
whose performance in the KPS equal to or lower than 
30% those with a KPS higher than 30%.
Methods
The protocol of this cross-sectional study was approved 
by the Ethics Committee Board of the Hospital de Clíni-
cas de Porto Alegre, Brazil (protocol no 2019–0207). All 
subjects gave their written formal consent for participa-
tion or their caregivers. Figure 1 presents the flow of the 
standardized phases of the study.
Phase I. Translation, synthesis and back translation 
and consensus of experts assessed the content and face 
validity
Previously published guidelines carried out the proce-
dures for the translation and cross-cultural adaptation of 
the MQOL-R to Brazilian Portuguese [10–13]. We fol-
low the recommended practices by the Health Measure-
ment Consensus guideline terminology (COSMIN) for 
assessing the content validity for health‐related Patients. 
According to the COSMIN, evaluating the content valid-
ity for health‐related Patient Reported Outcome Meas-
ures (PROMS) is categorized into three broad domains: 
Reliability, containing the Measurement and assessment 
of the conceptual semantics content of each item [14]. 
The procedures for assessing the semantics and con-
ceptual content of each item of the MQOL-R [14] were 
through the Delphi method [15]. The McGill Quality of 
Life Questionnaire-Revised (MQOL-R) validated for Bra-
zilian Portuguese is presented in Additional file 1.
Phase II. Pretesting of BrP‑MQOL‑R in a pilot study
Twenty patients assessed the comprehension of the item 
of BrP-MQOL-R. Among them, nine were inpatients, and 
11 were women. The median age was 59.50 [interquartile 
ranges IQR) (IQR 25–75 = 46.5; 73.75)] and the median 
of formal schooling was 8  years (IQR 25–75 = 5; 11), 
respectively. They evaluated the meaning of the trans-
lated questions and the layout of the pre-final version of 
the BrP-MQOL-R and assessed each item’s comprehen-
sion using a 10 cm visual analog scale (VAS; 0 completely 
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Fig. 1 Flow of the multiple standardized phases of the study. Abbreviations: Karnofsky Performance Status Scale (KPS); Numerical Pain Scale 
(NPS0-10)
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incompressible to 10  cm entirely clear). The median of 
comprehension of all items was 8.70 (IQR 25–75 = 7.56; 
10).
Phase III. Assessment of psychometric properties 
and the validity of the final version of the BrP‑MQOL‑R
A total of 157 patients over 18 years old at the Pain and 
Palliative Medicine Service of “Hospital de Clínicas de 
Porto Alegre, Brazil, from March 2019 to December 
2019. Sixty-four in patients (43.8%) and 82 (56.2%) outpa-
tients. Patients illiterate and those with cognitive impair-
ment that prevented them from answering questions or 
communicating were excluded. Data were obtained by 
trained evaluators using a standardized questionnaire, 
the MQOL-R, the Performance de Karnofsky Scale, and a 
Numerical Pain Scale (NPS 0–10).
Self‑report variables
NPS (0–10) was used to measure pain intensity, ranging 
from 0 (no pain) to 10 (the worst pain possible). They 
answered their pain level most of the time in the last 24 h 
and the pain score after taking pain medication.
The Karnofsky Performance Status Scale (KPS) was 
used to quantifying functional status. The KPS is an 
11-point rating scale that ranges from normal function-
ing (100) to dead (0). The KPS of < 30 the patients unable 
to perform these activities with or without assistance 
[16].
The McGill Quality of Life Questionnaire-Revised 
(MQOL-R) consists of 14 items divided into four 
domains: The Single-Item Scale (SIS), physical symptoms 
(three items), feelings and thoughts (seven items), and 
social (three items). The overall scale has good internal 
reliability (α = 0.94) [10].
Statistical analysis
We conducted descriptive statistics to examine the 
underlying assumptions of normality for all variables of 
interest. The Cronbach’s alpha and Spearman-Brown 
were used for the assessment of the MQOL-R’s reliabil-
ity. For the BrP-MQOL-R, the maximum likelihood fac-
tor analyses with oblique rotation were conducted. We 
checked the scale’s internal structure using confirma-
tory factor analysis (CFA) and establishing its reliabil-
ity and validity. Items with a loading equal to or higher 
than 0.4 were retained to be considered relevant [17]. 
Factors that win with eigenvalues greater than one were 
also excluded. Convergent validity was evaluated by Pear-
son’s correlation coefficient between BrP-MQOL-R total 
scores, subscales, and the SIS measuring overall quality 
of life with scores on NPS (0–10) and the KPS scale. The 
non-parametric receiver operating characteristics (ROC) 
analyses, with the exact binomial of the area under the 
curve (AUCs) with 95% confidence intervals (CI), is 
presented. We calculated the standard errors (SEs) by 
Hanley’s method [18]. The cutoff values with the high-
est Youden index, with 90% sensitivity and 100% speci-
ficity, are presented for the BrP-MQOL-R with a ROC 
AUC 0.70. Finally, a stratified-by-sex analysis was used 
to assess the correlation between age, education level, if 
they were hospitalized when they answered the MQOL-
R (Yes/No), and the scores of the dependent variable 
MQOL-R. We employed regression analysis with a step-
wise forward technique. The prior sample size was esti-
mated a priori based on the number of volunteers’ ratio 
to the number of items. In this case, the MQOL-R has 14 
questions. Based on this criterion, we needed 140 volun-
teers. Considering potential loss by insufficient data, we 
increased the sample size by 10% [10]. For all statistical 
analyses, significance was set at P < 0.05. The analysis 
used SPSS version 24.0 (IBM, Armonk, NY, USA), and 
the CFA was conducted by means of SPSS. AMOS. Ver-
sion 24.0 (IBM, Armonk, NY, USA).
Results
Phase III: assessment of psychometric properties 
and the validity of the final version of the Validation study
Sample characteristics
The demographic data and clinical characteristics are 
presented in Table  1. There was a proportionate num-
ber of females and males in our sample, 53.4% and 
46.6%, respectively. The mean scores of the BrP-MQOL-
R for males were 5.69 (1.63) and for females 5.69 (2.20) 
(t = 2.75, P = 0.007], respectively. The mean score on the 
BrP-MQOL-R for the total sample was 6.09 (SD = 2.0). 
The median of all items was 6.17 [interquartile (IQR25-
75) 4.67; 7.60].
Psychometric properties of the MQOL‑R‑ BrP
Internal consistency
The BrP-MQOL-R final 14-item had a satisfactory inter-
nal consistency (α = 0.85). The mean (SD) for all items of 
the scale was 6.09 [2].
The MQOL-R scale and subscales and the total result 
were scored by averaging across items. We checked 
whether the findings in subscales differ from one another; 
we conducted a one-way repeated-measures ANOVA. 
The data comply with the variance sphericity (Muycha-
ly’s test: W = 0.89, P = 0.008). This result indicates that 
the results in the MQOL-R sub-scales differ from one 
another. The multiple comparison test by Bonferroni 
revealed that QOL in the subscale social [mean (stand-
ard deviation)] was highest in our sample [8.14, (1.87); 
P < 0.001 for all comparisons], followed by existential 
[6.36 (2.10) P < 0.001 for all comparisons], psychological 
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[5.21 (2.60)], and physical [4.88 (2.01)]. Other compari-
sons returned no significant difference.
Construct validity: questionnaire item selection, structural 
validity and cross‑cultural‑validity
Confirmatory factor analysis of the MQOL‑R We tested 
the internal structure of the MQOL-R using CFA, using 
the generalized least squares method. CFA revealed that 
all items were related to four specified factors, verifying 
the item’s relationships and latent factors. Figure 2 shows 
the diagram and factor loading generated and presented 
in Table 2, the fit indices for this model. The analysis elic-
ited adequate model goodness of fit (Table 2). The χ2 test 
(CMIN = 117.38; df = 73; p = 0.001) suggests insufficient 
fit, although this statistical tool is too restrictive and often 
points to rejecting a model with high samples involved. 
The chi-square/degree of freedom (CMIN/df = 1.608) 
reached a satisfactory value under 5. Following the strat-
egy of presenting fit indices suggested by Hu and Bentler 
[19] if the root means the square error of approximation 
(RMSEA = 0.065; confidence interval 0.042–0.086) is 0.06 
or below, and the standardized root-mean-square residual 
(SRMR) is 0.08 or below, thus, the model fitting is good. 
Comparative Fit Index (CFI = 0.934; RMSEA = 0.065; 95% 
CI range 0.042, 0.086). The revised model has the following 
fit-indices: PCLOSE = 0.131, Tucker-Lewis Index (TLI) 
rho 2 = 0.918, incremental fit index (IFI) delta 2 = 0.936. 
A second-order factor model was specified (Fig. 2) to sup-
port the derivation of an MQOL-R total score.
Convergence validity
The correlation between the BrP-MQOL-R total scale 
and subscale scores is displayed in Table  4. Conver-
gence-related validity is also supported by significantly 
Table 1 Sociodemographic and Clinical Characteristics of the Study Sample (n = 146)
Characteristic Frequency (%) or mean (SD) Median (IQ 25–75)
Sex
 Male/female 78 (53.4%)/68 (46.6%)
Hospitalized
 Yes/no 64 (43.8%)/82 (56.2%)
Education (years) 6.81 (4.17) 6 (0; 17)
65.16 (14.04) 66 (58; 75)
Karnofsky performance status scale (KPS) 59.18 (21.38) 50 (40; 80)
Score ≤ 60/score > 61 42.77 (10.74)/80.79 (9.03) 50 (20; 60)/80 (70; 100)
Score NPS (0–10), most of the time in the last 24 h
 Cancer (yes/no) 4.4 (3.61)/4.74 (3.99) 5 (0; 10)/6 (0; 10)
Score on NPS (0–10) after use pain medication
 Cancer (yes/no) 2 (2.83)/2.21 (2.69) 0 (0; 10)/0 (0; 8)
Primary cancer clinical diagnosis Frequency (%)
Palliative care patients without cancer 44 (30)
Lung carcinoma 15 (10)
Head and neck cancer 15 (10)
Melanoma 4 (3)
Breast cancer 9 (6)
Adenocarcinoma 6 (4)
Esophagus cancer 9 (6)
Prostate carcinoma 13 (9)
Bowel cancer 1 (1)
Colorectal cancer 5 (3)
Stomach cancer 7 (5)
Lymphoma 1 (1)
Hepatoma 2 (1)
Endometrial cancer 4 (3)
Kidney cancer 2 (1)
Bladder cancer 2 (1)
Diagnosis to be confirmed 7 (5)
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positively correlated with higher levels in the BrP-
MQOL-R total scores and their subscales with both the 
KPS score and the SIS related to the quality of life. In 
contrast, the BrP-MQOL-R was conversely correlated 
with the pain scores in the NPS (0–10). Most of the 
time, patients with higher pain scores in the last 24  h 
and after use pain medication showed a lower score in 
the BrP-MQOL-R, or vice-versa.
The pain scores on NPS (0–10) in two conditions, 
the pain level on most of the time in the last 24 h and 
relive of pain score when you take pain medication. The 
mean (SD) on the KPS was 59.18 (21.38). The mean 
score (SD) in the SIS measuring overall quality of life 
was 6.5 (2.54). The mean (SD) on the question of their 
pain level on most of the time in the last 24 h was 4.50 
(3.72), and after taking pain medication was 2.06 (2.78).
Responsiveness and criterion‑group validity
The responsiveness of the BrP-MQOL-R can be seen by 
the mean (standard deviation) of the total score. Patients 
with KPS equal to or lower than 30% could be discrimi-
nated from those with scores on KPS higher than 30%; 
the score on the BrP-MQOL-R was 4.83 (1.77) vs. 6.36 
(1.95) (P = 0.00), respectively. Also, the scores of the QOL 
scale and subscales tend to be higher in subjects with 
the best functional status. That is means that this tool 
has properties to capture differences between patients 
in palliative care with the worst performance of those 
who have better functional status. We assessed the cri-
terion validity by the screening accuracy to discriminate 
patients with KPS equal to or lower than 30% (n = 25) 
those with scores on KPS higher than 30% (n = 121) by 
non-parametric receiver operating characteristics (ROC) 
Fig. 2 MQOL-R items and CFA for first order (subscale) and second order (overall QOL) latent factors. Factor loadings are standardized
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analyses an area under the curve (AUC) = 0.71, sensitiv-
ity = 97% and specificity = 92%).
A regression analysis was used to assess if sex, hospi-
talization, formal education, and age could influence the 
score in the BrP-MQOL-R. The variables retained in 
the model were sex and the hospitalization at the time 
of assessment, the beta-coefficient was − 0.86 (95% CI; 
− 1.49 to − 0.23; P = 0.00) and 0.78 (95% CI; 0.15 to 1.42; 
P = 0.01), respectively. That is, females and, if they were 
at home at the time of the assessment, showed higher 
scores.
Separate regression analyses were performed to deter-
mine the global BrP-MQOL-R score and a combination 
of the BrP-MQOL-R subscales to predict the SIS. These 
models were adjusted by hospitalization at the time of 
assessment adjusted and sex. The total score predicted 
similar variance in the SIS  (R2 adjusted = 0.36; β = 0.49, 
t = 4.50, p < 0.001) than those found in the MQOL-R 
subscales  (R2 adjusted = 0.36). A combination of two 
subscales was significant in predicting the SIS: Physi-
cal (β = 0.25, t = 2.43, p < 0.01) and Existential (β = 0.21, 
t = 2.29, p = 0.02).
Discussion
These results display data about the cross-cultural 
adapted to the English version of the BrP-MQOL-R. 
The process of translating and back translating the Eng-
lish BrP-MQOL-R to the Brazilian Portuguese transla-
tion was carried out stringently following established 
guidelines [10]. The set of questions of the BrP-MQOL-R 
presented satisfactory internal reliability with Cronbach’s 
alpha coefficients higher than 0.85, likewise to the origi-
nal English version. Our findings indicated an adequate 
construct validity and internal consistency of the BrP-
MQOL-R translated and adapted to Brazilian Portuguese 
[10]. They also showed that the items with higher load 
are those related to social and psychosocial, and the low-
est was found in the physical domains.
The content validity is evidenced by the high scores 
of the questionnaire items for readability, clarity, and 
comprehensiveness, as demonstrated by the scores on 
the visual analog scale in the assessment of the expert’s 
committee consulted. Likewise, the result was found in a 
sample of patients in palliative care. This process yielded 
a Brazilian Portuguese version of MQOL-R semantically 
equivalent to the English language MQOL-R. Thus, the 
current version of the BrP-MQOL-R can be used with-
out significant difficult in Portuguese-speaking popula-
tions. The test for internal consistency by Cronbach’s 
alpha indicates that either in the items and domains 
showed adequate consistency among their responses 
(see Tables  2, 3). These internal consistency coefficients 
by Cronbach’s alpha are like them obtained original scale 
[8].
CFA of the BrP-MQOL-R using a variety of different 
goodness of-fit model measures indicate an adequate 
construct validity. Like the original version, the model 
shows the goodness of fit with four factors: Existential, 
Table 2 Descriptive statistics, alpha coefficients for  scores on  the  Brazil adaptation of  the  McGill Quality of  Life 
Questionnaire-Items and the Total Score (n = 146)
QOL quality of life
* Reverse-scored items
Global QOL scores and items Mean (SD) Alfa de 
Cronbach
1. My physical symptoms were …. * 4.5 (3.6) 0.846
2. I felt (physically terrible–Physically well) 6.0 (2.9) 0.849
3. Being physically unable to do the things I wanted was…. * 4.1 (3.5) 0.855
4. I was depressed…..* 5.6 (3.8) 0.838
5. I was nervous or worried…..* 4.5 (3.7) 0.840
6. I felt sad….* 5.1 (4.0) 0.840
7. When I thought of the future…* 5.6 (3.8) 0.846
8. My life was…… 6.2 (3.5) 0.853
9. I feel in achieving life goals I have: Made no progress… 6.4 (3.2) 0.848
10. I felt that the amount of control I had over my… 6.1 (3.6) 0.844
11. I felt good about myself as a person… 6.7 (3.2) 0.839
12. Communication with the people I care about … 7.7 (2.9) 0.849
13. I felt my relationships with the people I care about were… 8 (2.7) 0.847
14. I felt supported… 8.6 (2.4) 0.855
BrP-MQOL total score 6. 15 (1.96) 0.854
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Social, Psychological, and Physical. [9] The CFA demon-
strated that all items of four factors showed a load facto-
rial higher than 0.4. This result indicates that all elements 
of each factor converge to a common point to consti-
tute a construct. Thus, our result confirms how well our 
analyzed variables represent the original constructs [9]. 
A strength of BrP-MQOL-R is items in each of the four 
subscales remain as proposed by Robin Cohen et al. [9] 
The CFA suggests that it is possible to maintain the origi-
nal structure scale items in the BrP-MQOL-R. Also, the 
factor analysis supports using separate scores for each 
one of the four domains.
We found moderate correlations between several 
domains, indicating that one life domain experience is 
related to other domains. Further, to examine the conver-
gence validity of BrP-QOL-R, we analyzed the strength of 
the relationship with the functional status by KPS score 
and in the SIS about the quality of life. All correlation 
among these factors showed correlations coefficients 
less than 0.5 (see Table  4). According to literature, the 
correlation for concurrent validity measure similar con-
cepts could not exceed 0.7 [20]. This way, the KPS scores’ 
correlation, either with the BrP-MQOL-R and their 
domains, indicates convergent validity. These results 
showed that these are measuring aspects of the same con-
struct but not in an identical way. The KPS evaluates the 
functional status at the end of life, such as the patient’s 
ability to carry on his everyday activity and work or his 
need for a specific custodial care amount dependence or 
constant medical care to continue alive. These simple cri-
teria serve to measure the burden that the patient’s care 
represents to his family or society and indirectly evaluate 
aspects of life quality. We used the same rationale related 
to the convergent validity to interpret the weak associa-
tion of the MQOL-R score with an SIS QOL (r = 0.33). 
However, in this case, the converse correction among the 
QOL score and their subscales indicates that this tool 
and its subscales can identify the negative impact of pain 
on life quality. From the clinical perspective, they support 
improving educational programs to improve pain man-
agement to relieve patients’ suffering in palliative care.
The relevance of these results is to evidence that the 
BrP-MQOL-R showed a sensibility identify the effect of 
factors that contribute to worst QOL either cancer or 
non-cancer patients. For example, the pain level, which 
is a specific aspect of healthcare, is a person-centered 
experience. In sum, these findings demonstrated that 
this tool validated and adapted to the Brazilian popula-
tion is suitable as part of an assessment of "quality of 
life" in patients in palliative care. Another measure that 
showed the theoretical construct of the BrP-MQOL-R 
is the criterion-validity to differentiate those patients 
unable to perform their activities with or without assis-
tance compared to those that need medical care but 
less than the distinguished group. Thus, this intensive 
process to establish the validity of the BrP-MQOL-R 
provided reliable support for its validity in more depth. 
Thereby, we can offer the Brazilian population an 
Table 3 Alpha coefficients for  scores on  the  Brazil 
adaptation of  the  McGill Quality of  Life Questionnaire-
Revised and their subscales (n = 146)
$  BrP-MQOL-R summary score calculated by taking the mean of the subscale 
scores to give each domain equal weight
Subscales Mean (SD) Alfa de 
Cronbach
BrP-MQOL-physical domain 4. 88 (2.43) 0.822
BrP-MQOL psychological domain 5. 22 (3.13) 0.817
BrP-MQOL existential domain 6. 36 (2.54) 0.816
BrP-MQOL social domain 8. 15 (2.25) 0.858
BrP-MQOL total  score$ 6. 15 (1.96) 0.740
Table 4 Correlations among  the  MQOL-RBr total scores and  their dominions, the  single-item related to  quality of  life, 
functional status, and severity of pain (n = 146)
** Correlation is significant at the 0.01 level (2-tailed)
* Correlation is significant at the 0.05 level (2-tailed)
(1) (2) (3) (4) (5) (6) (7) (8)
MQOL-RBr physical dominion (1) 1
MQOL-RBr psychological dominion (2) .57** 1
MQOL-RBr existential dominion (3) .43** .47** 1
MQOL-RBr social dominion (4) .28** .30** .43** 1
MQOL-RBr total score (5) .74** .84** .79** .60** 1
Single-item scale measuring overall quality of life (6) .26** .22** .29** .25** .33** 1
Karnowski Performance Scale (7) .47** .35** .34** .24** .46** .16* 1
Score on NPT (0–10) after use pain medication (8) − .37** − .40** − .20* − .12 − .37** − .27** − .17* 1
Score NPS (0–10), most of the time in the last 24 h (9) − .47** − .37** − .22** − .20* − .42** − .27** − .31** − 0.18*
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instrument to assess the quality of life" in palliative care 
adequately adapted. This is important to clinical and 
for research from a transcultural perspective. Notably, 
it would be a useful tool to evaluate how the impact of 
support pharmacological and non-pharmacological in 
palliative care in different cultures. Mainly because in 
patients under palliative care, the illnesses are in pro-
gress, and healthcare takes on an increasingly impor-
tant role day by day in these people’s life. Hence, the 
quality of life should be the most target in the care of 
these patients.
In the present study, males were associated with the 
worst quality of life compared to females. Accord-
ingly, prior research investigating sex differences in 
aggressiveness of end-of-life care preferences [21] and 
women are less likely to prefer life-sustaining technol-
ogy and other aggressive treatments. Also, they are 
more likely to give do-not-resuscitate orders to have a 
dignified death [21]. While another survey found that 
among patients with advanced cancer, women were 
more likely than men to recognize that their disease 
was incurable and at an advanced stage and report hav-
ing discussed life expectancy with their oncologist [22]. 
Another result that evidenced the discriminatory prop-
erties of the validated scale was identifying the worst 
quality of life of patients in the hospital compared to 
patients in palliative care at home. This finding is plau-
sible and supported by earlier surveys conducted in the 
United States (US), the UK, and the Netherlands, which 
reported that the quality of the end of life in hospitals 
was not satisfactory [23–25].
The main limitations of this study should be 
addressed. First, the test–retest was not performed. 
However, it is important to realize that the reliability 
of the test–retest gives more reliable results when a 
patient’s health status is stable at both times of the test 
[26]. In the context of palliative care, the clinical status 
changes faster sometimes in hours or in a few days at 
the way that this measure would be less reliable. Sec-
ond, the study is limited by the nonrandom selection of 
patients recruited in palliative care service at a univer-
sity hospital. Hence, selection bias is possible, and it is 
uncertain whether these findings can be extrapolated to 
patients receiving treatment in hospitals without pal-
liative care. However, it is noteworthy that our results 
are consistent with findings observed in the original 
English language version, which involved a variety of a 
representative national sample [27]. Third, the study is 
based on self-report measures. Thus, the comprehen-
sion of items content of the assessment instruments 
may have implications for the internal validity of the 
survey. Finally, longitudinal studies are required with a 
more significant number of clinical samples.
Conclusion
This study provided evidence for the validity, reliability 
and demonstrated that the psychometric properties of 
the BrP-MQOL are satisfactory. Also, it showed ade-
quate discriminate properties being sensitive to detect-
ing the general conditions of patients with a terminal 
disease involving patients in palliative care in Portu-
guese-speaking countries. In sum, they suggest that this 
scale represents a valuable instrument for use in scien-
tific studies and in the clinical setting involving patients 
in palliative care (Additional file 1).
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